Emergent Biosolutions's market cap is currently $451.90M. The company's EPS TTM is $-4.098; its P/E ratio is ―; Emergent Biosolutions is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-0.43. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 1.05B	$ 1.12B	$ 1.79B	$ 1.56B	$ 1.11B
Gross Profit	$ 343.90M	$ 427.20M	$ 1.04B	$ 1.03B	$ 672.50M
Operating Income	$ -726.40M	$ -166.00M	$ 352.60M	$ 433.80M	$ 114.10M
EBITDA	$ -505.30M	$ -32.90M	$ 458.20M	$ 549.00M	$ 227.30M
Net Income	$ -760.50M	$ -223.80M	$ 219.50M	$ 305.80M	$ 54.50M
Balance Sheet
Cash & Short-Term Investments	$ 111.70M	$ 642.60M	$ 576.10M	$ 621.30M	$ 167.80M
Total Assets	$ 1.82B	$ 3.17B	$ 2.96B	$ 2.88B	$ 2.33B
Total Debt	$ 860.20M	$ 1.41B	$ 841.00M	$ 874.80M	$ 811.30M
Net Debt	$ 748.50M	$ 763.20M	$ 264.90M	$ 253.50M	$ 643.50M
Total Liabilities	$ 1.17B	$ 1.78B	$ 1.34B	$ 1.44B	$ 1.24B
Stockholders' Equity	$ 649.30M	$ 1.38B	$ 1.62B	$ 1.45B	$ 1.09B
Cash Flow
Free Cash Flow	$ -257.90M	$ -149.90M	$ 96.10M	$ 395.00M	$ 101.10M
Operating Cash Flow	$ -206.30M	$ -34.10M	$ 321.10M	$ 536.00M	$ 188.00M
Investing Cash Flow	$ 212.30M	$ -381.30M	$ -225.00M	$ -151.00M	$ -96.90M
Financing Cash Flow	$ -535.70M	$ 481.20M	$ -141.00M	$ 69.50M	$ -35.90M

Currency in USD

Emergent Biosolutions Earnings and Revenue History

Income Statement >

Emergent Biosolutions Debt to Assets

Balance Sheet >

Emergent Biosolutions Cash Flow

Cash Flow >

Emergent Biosolutions Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing